COORDINATING EDITOR
Maurizio Gallieni - Milan, ItalyOspedale San Carlo Borromeo
Maurizio Gallieni was born in 1960 in Milan, Italy. He graduated in 1985 with honors from the School of Medicine at the University of Milan with a degree in Medicine and Surgery. He undertook additional training during medical school which included a course studying Nephrology in 1982 at the Brown University in Providence, Rhode Island, and research training with the Division of Nephrology at the University of Chicago in 1985. His extracurricular studies formed the basis for his M.D. thesis focusing on “inhibitors of kidney stone formation”. In 1989 he received his doctorate specializing in nephrology from the School of Medicine at the University of Verona, Italy with a doctoral thesis on “Vitamin D treatment of secondary hyperparathyroidism”.
Between 1991 and 1993 he served as a research fellow at the Washington University School of Medicine in St. Louis, Missouri, USA. During this time he conducted his research at a highly regarded laboratory in the field of renal osteodystrophy, managed by Professor Eduardo Slatopolsky.
His professional activity started in 1986 when he served as a Medical Officer in the Italian Army and was appointed Head of the Medical Service in the military barracks. Between 1989 and 1991 he served as Staff Nephrologist at the San Paolo Hospital in Milan, Italy, he went on to become Senior Nephrologist in 1993 and in 2001 Chief of the Sub-Unit “Renal Failure” and Vice Director of the Operative Unit of Nephrology and Dialysis, holding this position until 2009. He is currently Director of the Nephrology and Dialysis Unit at the San Carlo Borromeo Hospital in Milan, Italy.
Since 1997 he held several teaching positions at the University of Milan, Contract Professor of Nephrology at the Specialty School of Internal Medicine, Researcher and Aggregate Professor or Nephrology. The most recent position held since 2009 is Head of teaching for the Specialty School of Nephrology.
His main areas of interest are metabolic bone diseases, particularly osteodystrophy, kidney, anemia secondary to renal failure, vascular access for dialysis and Fabry’s disease. He has active collaborations focusing on the study of vascular access with the University of Texas in USA, and vascular calcifications in peritoneal dialysis with the University of British Columbia, Vancouver, Canada.
His scientific activity has resulted in over 130 publications indexed in PubMed with a total Impact Factor of 323. The majority of them relate to renal osteodystrophy; with others relating to aspects of care of nephrology and dialysis patients, including anemia and vascular access. He is a member of the Editorial Board of several leading international nephrology journals and is a member of nephrology and vascular access scientific societies in Europe and the USA. He is the President of the Vascular Access Society and, as of January 2006, Coordinating Editor of The Journal of Vascular Access.
He has a renowned international reputation in his main area of interest, osteodystrophy and is an opinion leader in the fast growing field of vascular access, receiving several reputable internal and international recognitions.